EUVIMEDEUVIMED entdecken
Multizentrische StudieKohortenstudie

Real-World Application of Oral Therapy for Infective Endocarditis: A Multicenter, Retrospective, Cohort Study

Sarah Freling, Noah Wald-Dickler iD, Josh Banerjee, Catherine P Canamar, Soodtida Tangpraphaphorn, Dara Bruce, Kusha Davar iD, Fernando Dominguez, Daniel Norwitz, Ganesh Krishnamurthi, Lilian Fung, Ashley Guanzon und 6 weitere

Clinical Infectious Diseases · 11.09.2023 · 77 (5) · 672-679

DOI: 10.1093/cid/ciad119 ↗

Kurz gefasst

Multizentrische Studie in der Zeitschrift Clinical Infectious Diseases, online erschienen am 07.03.2023. Verfasst von Sarah Freling und 17 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine and Infectious Diseases, Los Angeles County + University of Southern California Medical Center, Los Angeles, California, USA. Hauptthemen laut MEDLINE: Methicillin-Resistant Staphylococcus aureus, Endocarditis, Bacterial, Endocarditis, Bacteremia. Die Arbeit wurde bisher 60-mal zitiert (Crossref) und nennt 30 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

We sought to compare the outcomes of patients treated with intravenous (IV)-only vs oral transitional antimicrobial therapy for infective endocarditis (IE) after implementing a new expected practice within the Los Angeles County Department of Health Services (LAC DHS).

Methods

We conducted a multicentered, retrospective cohort study of adults with definite or possible IE treated with IV-only vs oral therapy at the 3 acute care public hospitals in the LAC DHS system between December 2018 and June 2022. The primary outcome was clinical success at 90 days, defined as being alive and without recurrence of bacteremia or treatment-emergent infectious complications.

Results

We identified 257 patients with IE treated with IV-only (n = 211) or oral transitional (n = 46) therapy who met study inclusion criteria. Study arms were similar for many demographics; however, the IV cohort was older, had more aortic valve involvement, were hemodialysis patients, and had central venous catheters present. In contrast, the oral cohort had a higher percentage of IE caused by methicillin-resistant Staphylococcus aureus. There was no significant difference between the groups in clinical success at 90 days or last follow-up. There was no difference in recurrence of bacteremia or readmission rates. However, patients treated with oral therapy had significantly fewer adverse events. Multivariable regression adjustments did not find significant associations between any selected variables and clinical success across treatment groups.

Conclusions

These results demonstrate similar outcomes of real-world use of oral vs IV-only therapy for IE, in accord with prior randomized, controlled trials and meta-analyses.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Methicillin-Resistant Staphylococcus aureusEndocarditis, BacterialEndocarditisBacteremiaStaphylococcal InfectionsAdultHumansRetrospective StudiesCohort StudiesAnti-Bacterial Agents

Stichwörter der Autor:innen

infective endocarditisoral stepdown antibiotic therapy

Substanzen

Anti-Bacterial Agents

Autor:innen und Institutionen

  • Department of Medicine and Infectious Diseases, Los Angeles County + University of Southern California Medical Center, Los Angeles, California, USA.
  • Department of Medicine, Keck School of Medicine-University of Southern California, Los Angeles, California, USA.
  • Department of Integrative Anatomical Sciences, Keck School of Medicine-University of Southern California, Los Angeles, California, USA.
  • Department of Pharmacy, University of Southern California Mann School of Pharmacy and Pharmaceutical Sciences, Los Angeles, California, USA.

ORCID-Profile: Noah Wald-Dickler, Kusha Davar

Zitieren

APA

Freling, S., Wald-Dickler, N., Banerjee, J., Canamar, C. P., Tangpraphaphorn, S., Bruce, D., Davar, K., Dominguez, F., Norwitz, D., Krishnamurthi, G., Fung, L., Guanzon, A., Minejima, E., Spellberg, M., Spellberg, C., Baden, R., Holtom, P., & Spellberg, B. (2023). Real-World Application of Oral Therapy for Infective Endocarditis: A Multicenter, Retrospective, Cohort Study. Clinical Infectious Diseases, 77(5), 672-679. https://doi.org/10.1093/cid/ciad119

Vancouver

Freling S, Wald-Dickler N, Banerjee J, Canamar CP, Tangpraphaphorn S, Bruce D, et al. Real-World Application of Oral Therapy for Infective Endocarditis: A Multicenter, Retrospective, Cohort Study. Clinical Infectious Diseases. 2023;77(5):672-679. doi:10.1093/cid/ciad119

BibTeX
@article{Freling2023,
  author = {Freling, Sarah and Wald-Dickler, Noah and Banerjee, Josh and Canamar, Catherine P and Tangpraphaphorn, Soodtida and Bruce, Dara and Davar, Kusha and Dominguez, Fernando and Norwitz, Daniel and Krishnamurthi, Ganesh and Fung, Lilian and Guanzon, Ashley and Minejima, Emi and Spellberg, Michael and Spellberg, Catherine and Baden, Rachel and Holtom, Paul and Spellberg, Brad},
  title = {Real-World Application of Oral Therapy for Infective Endocarditis: A Multicenter, Retrospective, Cohort Study},
  journal = {Clinical Infectious Diseases},
  year = {2023},
  volume = {77},
  number = {5},
  pages = {672--679},
  doi = {10.1093/cid/ciad119}
}
Kostenlos starten →